Year |
Citation |
Score |
2020 |
Amarouch MY, El Hilaly J. Inherited Cardiac Arrhythmia Syndromes: Focus on Molecular Mechanisms Underlying TRPM4 Channelopathies. Cardiovascular Therapeutics. 2020: 6615038. PMID 33381229 DOI: 10.1155/2020/6615038 |
0.508 |
|
2020 |
Amarouch MY, Kurt H, Delemotte L, Abriel H. Biophysical Characterization of Epigallocatechin-3-Gallate Effect on the Cardiac Sodium Channel Na1.5. Molecules (Basel, Switzerland). 25. PMID 32085432 DOI: 10.3390/Molecules25040902 |
0.614 |
|
2016 |
Boukhabza M, El Hilaly J, Attiya N, El-Haidani A, Filali-Zegzouti Y, Mazouzi D, Amarouch MY. Evaluation of the Potential Antiarrhythmic Effect of Epigallocatechin-3-Gallate on Cardiac Channelopathies. Computational and Mathematical Methods in Medicine. 2016: 7861653. PMID 27882075 DOI: 10.1155/2016/7861653 |
0.468 |
|
2016 |
Syam N, Chatel S, Ozhathil LC, Sottas V, Rougier JS, Baruteau A, Baron E, Amarouch MY, Daumy X, Probst V, Schott JJ, Abriel H. Variants of Transient Receptor Potential Melastatin Member 4 in Childhood Atrioventricular Block. Journal of the American Heart Association. 5. PMID 27207958 DOI: 10.1161/Jaha.114.001625 |
0.638 |
|
2016 |
Amarouch MY, Swan H, Leinonen J, Marjamaa A, Lahtinen AM, Kontula K, Toivonen L, Widen E, Abriel H. Antiarrhythmic Action of Flecainide in Polymorphic Ventricular Arrhythmias Caused by a Gain-of-Function Mutation in the Nav 1.5 Sodium Channel. Annals of Noninvasive Electrocardiology : the Official Journal of the International Society For Holter and Noninvasive Electrocardiology, Inc. 21: 343-51. PMID 26965448 DOI: 10.1111/Anec.12312 |
0.69 |
|
2016 |
Daumy X, Amarouch MY, Lindenbaum P, Bonnaud S, Charpentier E, Bianchi B, Nafzger S, Baron E, Fouchard S, Thollet A, Kyndt F, Barc J, Le Scouarnec S, Makita N, Le Marec H, et al. Targeted resequencing identifies TRPM4 as a major gene predisposing to progressive familial heart block type I. International Journal of Cardiology. 207: 349-58. PMID 26820365 DOI: 10.1016/J.Ijcard.2016.01.052 |
0.755 |
|
2016 |
Daumy X, Amarouch MY, Lindenbaum P, Bonnaud S, Charpentier E, Bianchi B, Nafzger S, Baron E, Fouchard S, Thollet A, Kyndt F, Barc J, Le Scouarnec S, Makita N, Le Marec H, et al. Targeted resequencing identifies TRPM4 as a major gene predisposing to progressive familial heart block type i International Journal of Cardiology. 207: 349-358. DOI: 10.1016/j.ijcard.2016.01.052 |
0.714 |
|
2015 |
Amarouch MY, Abriel H. Cellular hyper-excitability caused by mutations that alter the activation process of voltage-gated sodium channels. Frontiers in Physiology. 6: 45. PMID 25741286 DOI: 10.3389/Fphys.2015.00045 |
0.679 |
|
2015 |
Ossola D, Amarouch MY, Behr P, Vörös J, Abriel H, Zambelli T. Force-controlled patch clamp of beating cardiac cells. Nano Letters. 15: 1743-50. PMID 25639960 DOI: 10.1021/Nl504438Z |
0.601 |
|
2015 |
Saber S, Amarouch MY, Fazelifar AF, Haghjoo M, Emkanjoo Z, Alizadeh A, Houshmand M, Gavrilenko AV, Abriel H, Zaklyazminskaya EV. Complex genetic background in a large family with Brugada syndrome. Physiological Reports. 3. PMID 25626866 DOI: 10.14814/Phy2.12256 |
0.645 |
|
2015 |
Amarouch MY, Swan H, Leinonen J, Marjamaa A, Lahtinen AM, Kontula K, Toivonen L, Widen E, Abriel H. Antiarrhythmic Action of Flecainide in Polymorphic Ventricular Arrhythmias Caused by a Gain-of-Function Mutation in the Nav1.5 Sodium Channel Annals of Noninvasive Electrocardiology. DOI: 10.1016/S1878-6480(16)30436-0 |
0.659 |
|
2014 |
Amarouch MY, Kasimova MA, Tarek M, Abriel H. Functional interaction between S1 and S4 segments in voltage-gated sodium channels revealed by human channelopathies. Channels (Austin, Tex.). 8: 414-20. PMID 25483584 DOI: 10.4161/19336950.2014.958922 |
0.588 |
|
2014 |
Béziau DM, Barc J, O'Hara T, Le Gloan L, Amarouch MY, Solnon A, Pavin D, Lecointe S, Bouillet P, Gourraud JB, Guicheney P, Denjoy I, Redon R, Mabo P, le Marec H, et al. Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations. Basic Research in Cardiology. 109: 446. PMID 25341504 DOI: 10.1007/s00395-014-0446-5 |
0.454 |
|
2014 |
Swan H, Amarouch MY, Leinonen J, Marjamaa A, Kucera JP, Laitinen-Forsblom PJ, Lahtinen AM, Palotie A, Kontula K, Toivonen L, Abriel H, Widen E. Gain-of-function mutation of the SCN5A gene causes exercise-induced polymorphic ventricular arrhythmias. Circulation. Cardiovascular Genetics. 7: 771-81. PMID 25210054 DOI: 10.1161/Circgenetics.114.000703 |
0.659 |
|
2014 |
Coyan FC, Abderemane-Ali F, Amarouch MY, Piron J, Mordel J, Nicolas CS, Steenman M, Mérot J, Marionneau C, Thomas A, Brasseur R, Baró I, Loussouarn G. A long QT mutation substitutes cholesterol for phosphatidylinositol-4,5-bisphosphate in KCNQ1 channel regulation. Plos One. 9: e93255. PMID 24681627 DOI: 10.1371/journal.pone.0093255 |
0.435 |
|
2014 |
Amarouch MY, Leinonen J, Marjamaa A, Kucera JP, Laitinen-Forsblom PJ, Lahtinen AM, Palotie A, Kontula K, Toivonen L, Abriel H, Widen E, Swan H. 0265: A novel SCN5A mutation associated with exercise-induced polymorphic ventricular arrhythmias resembling CPVT Archives of Cardiovascular Diseases Supplements. 6: 41-42. DOI: 10.1016/S1878-6480(14)71376-X |
0.639 |
|
2014 |
Coyan FC, Amarouch M, Abderemane Ali F, Piron J, Mordel J, Nicolas CS, Steenman M, Mérot J, Marionneau C, Thomas A, Brasseur R, Baró I, Loussouarn G. In KCNQ1 Channels, a Long QT Mutation Induces a Regulation by Cholesterol Instead of Phosphatidylinositol-4,5-Bisphosphate Biophysical Journal. 106: 140a. DOI: 10.1016/J.BPJ.2013.11.814 |
0.372 |
|
2013 |
Amarouch MY, Syam N, Abriel H. Biochemical, single-channel, whole-cell patch clamp, and pharmacological analyses of endogenous TRPM4 channels in HEK293 cells. Neuroscience Letters. 541: 105-10. PMID 23428507 DOI: 10.1016/J.Neulet.2013.02.011 |
0.752 |
|
2013 |
Ossola D, Behr P, Amarouch M, Abriel H, Vörös J, Zambelli T. Fluidfm for Force Controlled Electrophysiology Biophysical Journal. 104: 502a. DOI: 10.1016/J.Bpj.2012.11.2771 |
0.478 |
|
2012 |
Laurent G, Saal S, Amarouch MY, Béziau DM, Marsman RF, Faivre L, Barc J, Dina C, Bertaux G, Barthez O, Thauvin-Robinet C, Charron P, Fressart V, Maltret A, Villain E, et al. Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy. Journal of the American College of Cardiology. 60: 144-56. PMID 22766342 DOI: 10.1016/j.jacc.2012.02.052 |
0.337 |
|
2012 |
Abriel H, Syam N, Sottas V, Amarouch MY, Rougier JS. TRPM4 channels in the cardiovascular system: physiology, pathophysiology, and pharmacology. Biochemical Pharmacology. 84: 873-81. PMID 22750058 DOI: 10.1016/J.Bcp.2012.06.021 |
0.645 |
|
2011 |
Piron J, Amarouch MY, Mordel J, Nicolas CS, Thomas A, Brasseur R, Charpentier F, Mérot J, Baró I, Loussouarn G. KCNQ1-R539W Mutation Substitutes Cholesterol for Phosphatidylinositol-4, 5-Bisphosphate in Channel Regulation Biophysical Journal. 100: 428a. DOI: 10.1016/j.bpj.2010.12.2530 |
0.377 |
|
2010 |
Rodriguez N, Amarouch MY, Montnach J, Piron J, Labro AJ, Charpentier F, Mérot J, Baró I, Loussouarn G. Phosphatidylinositol-4,5-bisphosphate (PIP(2)) stabilizes the open pore conformation of the Kv11.1 (hERG) channel. Biophysical Journal. 99: 1110-8. PMID 20712994 DOI: 10.1016/j.bpj.2010.06.013 |
0.443 |
|
2010 |
Piron J, Choveau FS, Amarouch MY, Rodriguez N, Charpentier F, Mérot J, Baró I, Loussouarn G. KCNE1-KCNQ1 osmoregulation by interaction of phosphatidylinositol-4,5-bisphosphate with Mg2+ and polyamines. The Journal of Physiology. 588: 3471-83. PMID 20660559 DOI: 10.1113/jphysiol.2010.195313 |
0.419 |
|
2010 |
Amarouch M, Saal S, Bertaux G, Faivre L, Baró I, Schott j, Kyndt F, Loussouarn G, Laurent G. Mutation of Cardiac Nav1.5 in an Hisian-Type Arrhythmia, Associated with Dilated Cardiomayopathy Biophysical Journal. 98: 311a. DOI: 10.1016/J.BPJ.2009.12.1688 |
0.333 |
|
2009 |
Amarouch M, Barc J, Béziau D, Kyndt F, Le Marec H, Babuty D, Probst V, Schott J, Baro I. G022 Loss-of-function mutation of the cardiac CAV1.2 channel in the short QT syndrome Archives of Cardiovascular Diseases. 102: S70. DOI: 10.1016/S1875-2136(09)72297-1 |
0.428 |
|
Show low-probability matches. |